...
首页> 外文期刊>World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons >Treatment When Prognostic Factors Do Not Match St. Gallen Recommendations: Profiling of Prognostic Factors among HR(+) and HER2(-) Breast Cancer Patients
【24h】

Treatment When Prognostic Factors Do Not Match St. Gallen Recommendations: Profiling of Prognostic Factors among HR(+) and HER2(-) Breast Cancer Patients

机译:预后因素与St. Gallen不匹配的治疗建议:HR(+)和HER2(-)乳腺癌患者的预后因素分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background The St. Gallen consensus provides treatment recommendations for breast cancer based on prognostic factors. Although many patients' prognostic patterns are not easily matched with the prognostic patterns listed in the St. Gallen consensus, there has been no systematic investigation reporting the gap between treatment recommendations and actual postoperative treatment choices in clinical practice.Methods Four hundred seventy-one patients with hormone receptor-positive [HR(+)] and human epidermal growth factor receptor type 2-negative [HER2(—)] breast cancer were analyzed. These patients were classified into either the "crisp treatment group" or "fuzzy treatment group" based on the definitiveness of postoperative treatment selection based on St. Gallen treatment recommendations. The patients in the fuzzy treatment group were further classified into strata in which patients within each stratum shared the same prognostic factor patterns with similar recurrence rates.
机译:背景St. Gallen共识基于预后因素为乳腺癌提供治疗建议。尽管许多患者的预后模式不容易与圣加仑共识中列出的预后模式相匹配,但尚无系统的研究报告治疗建议与临床实践中实际术后治疗选择之间的差距。方法471例患者对荷尔蒙受体阳性[HR(+)]和人表皮生长因子受体2型阴性[HER2(-)]乳腺癌患者进行了分析。根据基于圣加仑治疗建议的术后治疗选择的确定性,将这些患者分为“脆性治疗组”或“模糊治疗组”。模糊治疗组的患者被进一步分为不同的分层,其中每个分层内的患者具有相同的预后因素模式,复发率相似。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号